FICCI Young Leaders Summit 2025’ Debuts in Mumbai on 12th November

NEW DELHI, 04 November 2025: FICCI is organizing its flagship youth leadership event ‘Young Leaders Summit’, first time in Mumbai on 12th November at Hotel Taj Lands End. This milestone edition marks the Summit’s debut outside New Delhi, symbolizing the expansion of the FICCI Young Leaders Forum (FYL) to the nation’s financial and creative hub. The move underscores FICCI’s vision to take conversations on leadership, innovation, and youth-driven change to a broader, more diverse audience.



Over the years, the FICCI Young Leaders Summit has grown into one of India’s most influential forums for emerging leadership bridging the worlds of business, politics, technology, and culture.



The Summit in Mumbai will be inaugurated by Mr Ashish Shelar, Minister of Information Technology and Cultural Affairs, Government of Maharashtra. The inaugural session will also be addressed by Mr Harsha Vardhan Agarwal, President, FICCI and Vice Chairman & Managing Director, Emami Ltd., along with Mr Shashwat Goenka, Chair, FICCI Young Leaders Forum and Vice Chairman, RP-Sanjiv Goenka Group.



Other key leaders include Members of Parliament Mr Raghav Chadha, Mr Shrikant Eknath Shinde, and Mr Chandan Chauhan; Celebrity Chef Ranveer Brar; Wrestler Sangram Singh; Indraneel Chitale, Managing Partner at Chitale Bandhu; Anandmayee Bajaj, Managing Partner at Bajaj Group; Vasuki Punj, Founder of Frozen Fun Gelato; Rishikesh SR, Founder of Rapido; and Kunal Khambhati, Founder of District by Zomato, among others.



Throughout the day, delegates will engage in a series of sessions including startup policy and governance, artificial intelligence and the future of leadership, sustainable entrepreneurship, and creative economy innovation. The event will also witness speakers like Sumedha Chakraborty, Shruti Bhatia, and Rishabh Shroff, among many others sharing their thoughts. Curated fireside chats and next-generation leadership dialogues will offer candid, cross-sectoral perspectives on resilience, innovation, and purpose-driven success.



Adding to its forward-looking agenda, the 2025 edition will also mark the launch of new FICCI Young Leaders state chapters in Madhya Pradesh and Karnataka, a major step in expanding FYL’s presence and empowering young leaders across India’s regional ecosystems.

 

“No one could have told this story better than Jon,”_ : Ariana Grande on How It Was Director Jon M. Chu’s Destiny to Make _Wicked: For Good_*

*National, 4th November, 2025* : The magic of Oz is officially bigger, bolder, and more emotional than ever before. From the visionary director *Jon M. Chu* and *producer Marc Platt* , comes the much-awaited conclusion to one of cinema’s most beloved musical sagas – _Wicked: For Good_ . Starring *Academy Award®-nominated powerhouses Cynthia Erivo* and *Ariana Grande* , *Universal Pictures India* (Distributed by Warner Bros. Discovery) presents the highly anticipated finale, soaring into cinemas *21st November, 2025* .

Elphaba ( *Erivo* ), now painted as The Wicked Witch of the West, hides in the Ozian forest while fighting for the freedom of Oz’s silenced Animals and trying to expose the truth about The Wizard ( *Jeff Goldblum* ). Glinda ( *Grande* ), meanwhile, has become the glamorous symbol of Goodness, living at the palace in Emerald City under the instruction of Madame Morrible ( *Michelle Yeoh* ). As she prepares to marry Prince Fiyero ( *Jonathan Bailey* ), she is haunted by her separation from Elphaba. As an angry mob rises against the Wicked Witch, Glinda and Elphaba must come together one final time – discovering that true magic lies in empathy, honesty, and friendship.

_“It was clear when we separated the two movies that Wicked: For Good needed some additional elements to fully tell the story of these two women and their struggle to come back together,”_ says *Chu* on what the entire emotional arc of the first film was building toward. _“Because now, the world is wedged between their friendship and that is a much harder mechanism to fight through than just cultural or personality differences. Now there is literal structure and government between them. Deep down, we knew that Wicked: For Good was always going to be the bigger story. The kids we fell in love with in the first film now have to grow up, and they have to make choices that will last a lifetime. This isn’t school anymore.”_

_“Jon Chu is the most empathetic, intentional, brilliant and thoughtful human being with an innate understanding of the human experience,”_ notes *Ariana Grande* . _“He has taken such care of Oz, and he has protected these characters and showcased the humanness in all of them. He answers the question ‘are people born wicked or do they have wickedness thrust upon them’ a handful of times for us with this film. Decisions that might seem wicked on paper become understandable because of how he frames them with an empathetic lens and takes the time to tell you where these characters are coming from, showcasing that most perpetrators once were victims themselves. His heart and character are woven through every stitch of these films. Shooting two movies at once meant constant shifts in tone and spontaneous changes to the schedule, but he never blinked. No one could have told this story better than Jon. It was absolutely his destiny to make these films.”_

*Experience the magic, the music and the friendship – for good. _Wicked: For Good_ opens in cinemas 21st November, 2025!*

 

SS Innovations International along with the Association of Cardiac Surgeons – Mumbai showcased the Future of Robotic Cardiac Care through Continuing Medical Education

CME focused on the transformative role of the SSII Mantra Surgical Robotic System is revitalizing robotic cardiac surgery
SSII Mantra, India’s first CDSCO-approved surgical robotic system for both Tele-proctoring and Telesurgery, brings precision and accessibility to complex surgical procedures.
The advancements in technology paving the way for minimally invasive, high-precision procedures, the SSII Mantra Surgical Robotic System shaping the future of cardiac surgical care
Robotic Cardiac CME brings together global and renowned cardiac surgeons from Mumbai to share insights on clinical experiences, advancements in robotic-assisted cardiac surgeries, and the growing role of the SSI Mantra robotic system in cardiac surgery

Mumbai, 1st November 2025: Continuing its mission to revolutionize surgical innovation and make world-class healthcare accessible, SS Innovations International Inc., the pioneer behind India’s first and only indigenously developed Surgical Robotic System SSII Mantra, in association with the Association of Cardiac Surgeons, Mumbai, organized a Robotic Cardiac Continuing Medical Education (CME) program on the Cutting-Edge Cardiac Surgical Care and explored the transformative role of India’s indigenous SSII Mantra Surgical Robotic System is Reshaping Robotic Cardiac Surgery.

The Robotic Cardiac CME program convened some of the eminent Indian and Global cardiac surgeons, physicians and medical experts from across Maharashtra, various parts of India and around the world – marking another milestone in SS Innovations International’s journey to redefine the future of robotic-assisted cardiac surgery through innovation, accessibility, and indigenous excellence. The one-of-a-kind Robotic Cardiac CME program served as a pioneering platform for knowledge exchange among the leading cardiac surgeons, showcasing the evolution and impact of surgical robotics in cardiac care. More than 300 cardiac surgeons, doctors and medical professionals participated and witnessed the growing adoption of the SSII Mantra Surgical Robotic System, the world’s first Made-in-India, technologically advanced surgical robotic system. With its precision, adaptability, and cost-effectiveness, the SSII Mantra is bridging the gap between advanced technology and accessibility in India’s healthcare ecosystem.

This unique Robotic Cardiac CME featured expert sessions from some of the most distinguished and globally acclaimed leaders in robotic cardiac surgery, including Dr. T. Sloane Guy, Director, Minimally Invasive and Robotic Cardiac Surgery, Georgia Heart Institute (USA); Dr. Vishwa Pascual Srivastava, Managing Director and Chief Executive Officer – APAC, SS Innovations International; Dr. Ritwick RAJ Bhuyan, Director, Cardiothoracic & Vascular Surgery, Fortis Escorts Heart Institute, New Delhi; Dr Shantesh Kaushik, MD, Consultant Cardio-Thoracic & Vascular Surgeon, Apollo Hospitals; Dr. Anvay Mulay, Director, Cardiac Surgery Department, Sir H. N. Reliance Foundation Hospital; and Dr. Anvay Mulay, Director, Cardiac Surgery Department, Sir H. N. Reliance Foundation Hospital amongst others.

Speaking on the occasion the world renowned Doctor Devendra Saxena, Prof. of Surgery, Director, Robotic and Minimally Invasive Cardiac Surgery, The University of Chicago Medicine, Chicago (USA), said, “The Robotic Cardiac CME exemplifies how technology, collaboration, and clinical excellence come together to create a new paradigm in patient care. The SSII Mantra Surgical Robotic System empowers surgeons with precision and versatility while driving down costs, thereby bringing the benefits of robotic surgery to every corner of the country.”

Speaking at the Robotic CME program, Dr. Sudhir Srivastava, Founder, Chairman & CEO of SS Innovations, said, “The SSII Mantra represents the realization of India’s vision for self-reliance in advanced medical technology. Designed and built in India, it is a highly efficient and affordable surgical robotic system that is transforming access to world-class robotic surgery for millions. Our goal is to ensure that robotic surgery is not a privilege but a standard of care accessible, cost effective, and impactful. The mission is to democratize access to cutting-edge surgical technology by making robotic-assisted surgery more affordable and accessible. The SSII Mantra represents India’s spirit of innovation — designed, developed, and manufactured indigenously to serve both national and global healthcare needs.”

The Robotic Cardiac CME program emphasised on the increasing role of robotic technology in achieving superior surgical outcomes, reducing recovery times, and expanding the reach of minimally invasive cardiac procedures to hospitals across India. The program also served as a collaborative learning opportunity for surgeons to exchange insights and explore the integration of indigenous innovation into everyday cardiac practice.
The highlight of the session was the focus on the thought-provoking presentations and case experiences using the Made in India, SSII Mantra Surgical Robotic System from renowned cardiac surgeons, who have successfully pioneered robotic cardiac surgery in India and globally:

The session by Dr. Husam Balkhy, Professor of Surgery & Director, Robotic Cardiac Surgery, University of Chicago Medicine (USA) emphasised on the SSII’s Mantra Surgical Robotic System is helping advance robotic cardiac surgery globally;

The session of Dr. Lalit Aditya Malik, Chief Surgeon, Dept. of Robotic & Minimally Invasive Cardiac Surgery, Manipal Hospital Jaipur shared his clinical/surgical experience using the SSII Mantra Robotic System, highlighting its precision and adaptability.

Dr. Nitin Kumar Rajput, Associate Director – Cardiac Surgery Medanta – The Medicity, Gurugram also shared his experience being the first cardiac surgeon in India to use the Mantra System, spoke about his pioneering experience and the transformative impact on patient outcomes.

Dr. Ritwick Bhuyan, Director, Cardiothoracic & Vascular Surgery, Fortis Escorts Heart Institute, New Delhi shared insights from Fortis Escorts Heart Institute, outlining both challenges and successes in adopting robotic cardiac surgery with the SSII Mantra Surgical system.

Dr. Harish Badami, Senior Consultant CTVS, Specialist MICS (Robotics), Malla Reddy Narayana Multispeciality Hospital, Telangana session highlighted the rapid and independent adoption of the SSI Mantra System for cardiac surgery, reinforcing its growing acceptance and scalability across medical institutions.

This exceptional Robotic Cardiac CME program underscored the increasing role of robotic technology in enhancing surgical precision, improving patient outcomes, and broadening the reach of minimally invasive cardiac procedures to hospitals across India and globally. This program also served SS Innovations International’s commitment to fostering clinical learning, promoting indigenous innovation, and expanding the adoption of robotic surgery across specialties. The SSI Mantra continues to reinforce India’s growing leadership in global health-tech and the evolution of accessible, cutting-edge surgical care.



About Association of Cardiac Surgeons, Mumbai:

(SSII to share)

About SS Innovations International, Inc:

SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSII Mantra” surgical robotic system and its comprehensive suite of “SSII Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery.  An American company headquartered in India, SS Innovations International plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

About SSII Mantra:

The SSII Mantra Surgical Robotic System, by SS Innovations International Inc., is a modular multi-arm system with many advanced technology features. It allows for the use of 3-5 robotic arms, has an open-faced ergonomic Surgeon Command Centre, 32-inch large 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the Surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are over 40 different types of robotic endo-surgical instruments that can be used for different specialties including Cardiac Surgery. The learning curve is short due to its very thoughtful and ergonomic design and user-friendly features.